ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS
Clinical trials for ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS explained in plain language.
Never miss a new study
Get alerted when new ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS trials appear
Sign up with your email to follow new studies for ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug could tame severe asthma and fungal allergy
Disease control Recruiting nowThis study tests a drug called benralizumab (Fasenra) in 20 adults with severe asthma and a fungal allergy called ABPA. The goal is to see if it can reduce asthma flare-ups that need steroids and improve quality of life. Participants receive the drug as a shot under the skin, and…
Matched conditions: ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS
Sponsor: Qianfoshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New biologic combo aims to tame rare lung fungal allergy
Disease control Recruiting nowThis study looks at whether adding a biologic drug to standard treatment can reduce flare-ups in people with allergic bronchopulmonary aspergillosis (ABPA) and severe asthma. About 50 adults will receive a biologic for at least 4 months while continuing their usual asthma medicat…
Matched conditions: ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS
Sponsor: Qianfoshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Steroid combo may improve tough lung fungus treatment
Disease control Recruiting nowThis study looks at people with a mix of two lung conditions caused by the fungus Aspergillus: chronic pulmonary aspergillosis and allergic bronchopulmonary aspergillosis. Researchers want to see if adding steroid pills to the standard antifungal drug itraconazole works better th…
Matched conditions: ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS
Phase: NA • Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New bronchoscopic combo treatment aims to clear mucus plugs in ABPA patients
Disease control Recruiting nowThis study is for people with allergic bronchopulmonary aspergillosis (ABPA), a lung condition caused by an allergic reaction to a fungus. The treatment involves using a bronchoscope (a thin tube inserted into the airways) to clear mucus plugs and spray an antifungal drug (amphot…
Matched conditions: ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS
Sponsor: Qianfoshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
1500 patients join quest to decode bronchiectasis in china
Knowledge-focused Recruiting nowThis study aims to better understand bronchiectasis, a chronic lung disease, in Chinese patients. Researchers will collect data from 1500 adults to identify different disease types and their underlying causes. The goal is to improve diagnosis and tailor treatments for each patien…
Matched conditions: ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS
Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC